The company

The company MimeTech Srl was incorporated in December of 2004 by two scientists, Antonio Guarna, Professor of Organic Chemistry, and Federico Cozzolino, Professor of Clinical Laboratory Sciences, both at the University of Firenze, to further...
Read more "The company"

The technology

At the hub of our technology platform is a cutting-edge series of synthetic neurotrophin mimetics. The flaghship compound, whose name is Udonitrectag, is endowed with potent NGF (Nerve Growth Factor) as well as BDNF (Brain-Derived...
Read more "The technology"

Therapeutic solutions

As the therapeutic approach toward degenerative diseases has so far been inadequate, an enormous medical need still remains unmet. Our technology has proven highly effective in the most reputed animal models of critical human diseases...
Read more "Therapeutic solutions"

Therapeutic solutions

Ophthalmic diseases

Our synthetic neurotrophin mimetics are intended for treatment of corneal...
Read More "Ophthalmic diseases"

Cardiovascular diseases

Acute myocardial infarction (AMI), commonly known as a heart attack, occurs when...
Read More "Cardiovascular diseases"

Neurodegenerative diseases

Our synthetic neurotrophin mimetics may be used for treatment of...
Read More "Neurodegenerative diseases"

Dermatologic diseases

Pressure ulcers, also known as pressure sores, bedsores, and decubitus ulcers, are localized injuries...
Read More "Dermatologic diseases"

Solid organ transplant

Solid organs destined to transplantation undergo ischemic damage as soon...
Read More "Solid organ transplant"

Rare diseases

Rare diseases under evaluation Amyotrophic lateral sclerosis Synonym(s) Charcot disease, Lou...
Read More "Rare diseases"